Drug Report History

Return to report

Below you will find the report version history. When a report is updated, a new version of the report is created. The report history allows you to see the changes between versions. You can select two versions of the report to compare. The fields that were changed between versions will be highlighted in yellow.

The translation of reports creates two separate versions which is why some reports may not seem to have any differences. In this case, only the language field below will be highlighted in yellow.

Version v8-FR Version v1-EN
Language French English
Date Updated 2023-01-24 2023-01-06
Drug Identification Number 02392763 02392763
Brand name TRANEXAMIC ACID INJECTION TRANEXAMIC ACID INJECTION
Common or Proper name Tranexamic Acid Injection Tranexamic Acid Injection
Company Name OMEGA LABORATORIES LIMITED OMEGA LABORATORIES LIMITED
Ingredients TRANEXAMIC ACID TRANEXAMIC ACID
Strength(s) 100MG 100MG
Dosage form(s) SOLUTION SOLUTION
Route of administration INTRAVENOUS INTRAVENOUS INTRAVENOUS INTRAVENOUS
Packaging size 1 x 50mL vial / fiole 1 x 50mL vial / fiole
ATC code B02AA B02AA
ATC description ANTIFIBRINOLYTICS ANTIFIBRINOLYTICS
Reason for shortage Demand increase for the drug. Demand increase for the drug.
Anticipated start date 2023-01-25 2023-01-13
Actual start date
Estimated end date 2023-01-31 2023-01-23
Actual end date 2023-01-24
Shortage status Avoided shortage Anticipated shortage
Tier 3 Status No No
Company comments Stock available at Guelph and CPDN - Calgary and Vaughan.
Health Canada comments